Corporate Profile
Millipore (NYSE: MIL) is an innovative life science partner that propels our customers forward with the consumable products and services they need to confront challenging human health issues. Bringing our industry leadership and unparalleled scientific expertise, we engage in peer-to-peer discussions that advance the discovery, development, and production capabilities of leading academic, biotech and pharmaceutical customers. We ignite breakthrough innovations by collaborating with our customers in areas such as cell biology, protein research, and biopharmaceutical production. With more than 6,100 employees worldwide, Millipore is an S&P 500 company with operations in more than 47 countries.
More than 90 percent of Millipore’s revenues come from consumable products and services. The Company is organized in two divisions: the Bioprocess Division, which represents approximately 60 percent of the Millipore’s revenues and Bioscience Division, which represents 40 percent. Millipore’s Bioprocess Division helps pharmaceutical and biotechnology companies to optimize their manufacturing productivity, ensure the quality of drugs, and scale up the production of difficult-to-manufacture biologics. The Company’s Bioscience Division helps optimize laboratory productivity and workflows by providing sample preparation, reagents, kits, services and other enabling technologies and products for life science research and development.
Millipore Fact SheetQuick Facts
Everything you need to know about Millipore at a glance.
Executive Management
Meet Millipore's Top Executive Officers.
Board of Directors
Read biographies of Millipore's Board of Directors.
Acquisitions
As part of its strategy launched in 2005, Millipore has actively acquired companies to broaden its product portfolio and strengthen its capabilities.
Learn about how the company was started, how it grew, and how our capabilities have evolved.
Millipore Contact InformationIR SERVICES
Sign up for company alerts and download reports.
FAQs
Email Subscriptions
Download Documents
Order Reports| 20 minutes delayed |
Safe Harbor Statement
The information on the Millipore investor relations website, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.